More tools:Markets·Screener·Research·Chat

Penumbra, Inc. (PEN) Financial Statements

Penumbra, Inc.
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001TRHPB0
XNYS · usd
319.26▼ 2.91 (-0.90%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close322.17
Day's Range319.18 – 322.61
52-Week Range221.26 – 362.46
Volume380.8K
Avg Volume269.5K
Share Statistics
Shares Outstanding
Employees4,700
ExchangeXNYS
Listed2015-09-18
Share count as of July 14, 2026
Loading Income Statement…
Key questions about Penumbra, Inc. (PEN)
What is Penumbra, Inc.'s Market Cap?
Penumbra, Inc.'s Market Cap is $12.6B, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s Enterprise Value?
Penumbra, Inc.'s Enterprise Value is $12.4B, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s Trailing P/E?
Penumbra, Inc.'s Trailing P/E is 78.3×, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s Price / Sales?
Penumbra, Inc.'s Price / Sales is 8.4×, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s EV / Revenue?
Penumbra, Inc.'s EV / Revenue is 8.2×, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s EV / EBITDA?
Penumbra, Inc.'s EV / EBITDA is 61.2×, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s Revenue (TTM)?
Penumbra, Inc.'s Revenue (TTM) is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s Net Income (TTM)?
Penumbra, Inc.'s Net Income (TTM) is $160.6M, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s EBITDA?
Penumbra, Inc.'s EBITDA is $204.5M, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s Diluted EPS (TTM)?
Penumbra, Inc.'s Diluted EPS (TTM) is 4.08, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+14.9%+15.6%+22.1%+17.8%
Cost of revenue
Gross profit
% of revenue67.9%67.6%68.0%67.8%
Operating expenses:
Research and development
Sales, general and administrative
Total operating expenses
% of revenue57.4%57.4%52.6%54.0%
Income from operations
% of revenue10.5%10.2%15.4%13.8%
Interest and other income, net—
Income before income taxes
Provision for income taxes
Net income
% of revenue8.9%8.7%12.3%12.9%
Basic (in dollars per share)
Diluted (in dollars per share)